Results

Total Results: over 10,000 records

Showing results for "risk".

161. Evidence Summary: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary--html/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - For the Framingham Risk Score–based analyses, which used 3 risk strata, the top 2 risk strata (10%-20% … Combining risk markers improves cardiovascular risk prediction in women. … Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk … POPADAD, Prevention of Progression of Arterial Disease and Diabetes; RCT, randomized clinical trial; RR, relative … risk.

162. Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
     August 20, 2019 - Importance: Pathogenic mutations in breast cancer susceptibility genes BRCA1 and BRCA2 increase risks … In 8 RCTs (n = 54,651), tamoxifen (relative risk [RR], 0.69 [95% CI, 0.59-0.84]; 4 trials), raloxifene … Two studies indicated women have less understanding of their risks after genetic counseling, 64 , 70 … for primary care settings that evaluate individual risks can accurately guide referrals for genetic … Ovarian Cancer Research Group Netherlands; HR, hazard ratio; NA, not applicable; NR, not reported; RR, relative

163. Risk Management and Patient Safety | PSNet
     psnet.ahrq.gov/perspective/risk-management-and-patient-safety
     December 01, 2010 - companies.( 3 ) Professional liability insurers have long recognized the value of controlling systems risks … Since its creation in 1976, Risk Management Foundation (RMF) has created a robust program of risk management … Risk retention group offers incentive to reduce claims frequency. Risk Retention Reporter. … as risk financing, risk control, and proactive risk management. … So you may as well manage your risk as opposed to react to your risk.

164. Risk of mistaken DNR orders. | PSNet
     psnet.ahrq.gov/issue/risk-mistaken-dnr-orders
     October 19, 2022 - Study Risk of mistaken DNR orders. … Risk of mistaken DNR orders. … Risk of mistaken DNR orders.

165. Archived: Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/reducing-risk-for-mother-to-infant-transmission-of-hepatitis-c-virus-a-systematic-review-for-the-us-preventive-services-task-force/hepatitis-c-screening-2013
     November 15, 2012 - Although antiviral therapies are contraindicated in pregnancy because of teratogenic risks, prenatal … after vaginal or emergent cesarean delivery compared with no cases after 12 elective cesarean births (relative … ratio, 6.7 [CI, 1.1 to 36]), but another, larger good-quality study ( n  = 724) found no association (relative … Paediatric Hepatitis C Virus Network; HCV = hepatitis C virus; NR = not reported; OR = odds ratio; RR = relative … risk; SD = standard deviation

166. Recommendation: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - Risk factors can be combined in many ways to classify a person's risk for a CVD event. … Risk Score, incorporates hsCRP level into its risk calculation. … at intermediate risk. … year risk of 7.5% or greater are considered at high risk. 4 The distribution of estimated CVD risk in … 7.5% for increased risk.

167. Current and emerging infectious risks of blood transfusions. | PSNet
     psnet.ahrq.gov/issue/current-and-emerging-infectious-risks-blood-transfusions
     June 09, 2021 - Study Current and emerging infectious risks of blood transfusions. … Current and emerging infectious risks of blood transfusions. JAMA. 2003;289(8):959-62. … Current and emerging infectious risks of blood transfusions. JAMA. 2003;289(8):959-62.

168. Topic 0438 Risk stratification and CAD NSD FINAL_SJ-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
     May 29, 2025 - Topic 0438 Risk stratification and CAD NSD FINAL_SJ-2 Risk stratification …  The topic, Non-invasive Tests to Diagnose Patients with Suspected Coronary Artery Disease and to Risk … Non-invasive Tests to Diagnose Patients with Suspected Coronary Artery Disease and Summary: to Risk … Multiple non-invasive tests (NITs) are available to aid the evaluation of patients at intermediate risk … There is no clear guidance of what the test or combination of tests to use for patients with different risks

169. Recommendation: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     September 19, 2024 - Share to WhatsApp Share to Email Print Enhanced Risk … See Current Final Recommendation Statement for Cardiovascular Disease: Risk Assessment With Nontraditional … Risk Factors(2018) Final Research Plan Supporting Evidence Related Resources & Tools

170. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Events: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - In analyses of all doses, aspirin reduced the risk for nonfatal myocardial infarction (MI) (relative … risks (RRs) from the included CVD primary prevention trials evaluating aspirin doses of 100 mg or less … Bleeding risks with aspirin use for primary prevention in adults: a systematic evidence review for the … Figure 1 displays a forest plot of studies reporting the relative risk for the intervention group versus … Figure 2 displays a forest plot of studies reporting the relative risk for the intervention group versus

171. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
     August 20, 2019 - MD IMPORTANCE Pathogenic mutations in breast cancer susceptibility genes BRCA1 and BRCA2 increase risks … In 8 RCTs (n = 54 651), tamoxifen (relative risk [RR], 0.69 [95% CI, 0.59-0.84]; 4 trials), raloxifene … trials), and aromatase inhibitors (RR, 0.45 [95% CI, 0.26-0.70]; 2 trials) were associated with lower risks … Ovarian Cancer Research Group Netherlands; HR, hazard ratio; NA, not applicable; NR, not reported; RR, relative … Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

172. Using an automated risk assessment report to identify patients at risk for clinical deterioration. | PSNet
     psnet.ahrq.gov/issue/using-automated-risk-assessment-report-identify-patients-risk-clinical-deterioration
     February 15, 2017 - Commentary Using an automated risk assessment report to identify patients at risk … Using an automated risk assessment report to identify patients at risk for clinical deterioration. … Using an automated risk assessment report to identify patients at risk for clinical deterioration.

173. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
     cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
     September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk … to address this risk. 2. … DeFelippis AP, Young R. (2016) Estimating Longitudinal Risks and Benefits from Cardiovascular Preventive … 2017 at: http://www.acc.org/latest-in-cardiology/articles/2016/11/04/08/56/estimating-longitudinal- risks-and-benefits-from-cv-preventive-therapies

174. Final Progress Report: Gastrointestinal Safety of Antithrombotic Drug Regimens (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/abraham-report.pdf
     January 01, 2024 - thromboembolism, or post-acute coronary syndrome using administrative data, studying heterogeneity of risks … PURPOSE/STUDY OBJECTIVES Aim 1: To determine how GIB risk (total-, upper- and lower-GIB risk) among … Our study results demonstrate that these risks may be similar, and, in some individuals, the use … approaches to mitigate risk. … claims data of ACS patients following PCI, we discovered that ticagrelor was associated with a 25% relative

175. A Multi-Site Trial to Test Benefits of Adding a Personalized Risk Calculator to an Online Decision Aid for Left Ventricular Assist Device | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/multi-site-trial-test-benefits-adding-personalized-risk-calculator-online
     July 31, 2025 - A Multi-Site Trial to Test Benefits of Adding a Personalized Risk Calculator to an Online Decision Aid … guides their understanding of how treatment options align with their expressed values, personalized risk … However, given the highly variable individual risks and outcomes, uncertainty remains over which patients … There is a growing need for more personalized approaches to risk prediction and shared decision making … offer patients a better understanding of how treatment options align with their values and personalized risks

176. The coronavirus and the risks to the elderly in long-term care. | PSNet
     psnet.ahrq.gov/issue/coronavirus-and-risks-elderly-long-term-care
     July 15, 2020 - Commentary The coronavirus and the risks to the elderly in long-term care. … The coronavirus and the risks to the elderly in long-term care. … The coronavirus and the risks to the elderly in long-term care. … June 2, 2021 Registered nurses' judgments of the classification and risk level of patient … September 16, 2020 For-profit long-term care homes and the risk of COVID-19 outbreaks

177. Zvvry6Wa4Sgj-Ejb3Brcvy (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
     November 01, 2013 - that treatment with tamoxifen or raloxifene can significantly reduce the relative risk (RR) for invasive … BCPT � Breast Cancer Prevention Trial; IBC � invasive breast cancer; RR � relative risk; STAR � Study … BCPT � Breast Cancer Prevention Trial; IBC � invasive breast cancer; RR � relative risk; STAR � Study … BCPT � Breast Cancer Prevention Trial; IBC � invasive breast cancer; RR � relative risk; STAR � Study … BCPT � Breast Cancer Prevention Trial; IBC � invasive breast cancer; RR � relative risk; STAR � Study

178. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
     September 19, 2014 - The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain Evidence-Based Practice … receiver operating characteristic curve (AUROC).34,35 For studies of interventions, we calculated relative … risks (RR) and associated 95 percent confidence intervals (CI) based on the information provided ( … The effectiveness and risks of long-term opioid treatment of chronic pain. … The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain.

179. Archived: Physical Activity Promotion: Behavioral Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/physical-activity-promotion-behavioral-counseling-1996
     January 01, 1996 - Two recent large studies provide estimates of the relative risk of triggering myocardial infarctions … These relative risks are 2.1 (95% confidence interval, 1.6 to 3.1) 109 and 5.9 (4.6-7.7), 110 respectively … As the frequency of exercise per week increased, the relative risk of infarction during vigorous activity … First, given the sizable independent relative risk for impaired health in sedentary individuals together … Risks of exercising: cardiovascular, including sudden cardiac death.

180. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Estimates of risk ratios (RRs [rate ratio, hazard ratio, or relative risk]) and their standard errors … Risks for thromboembolic events and endometrial cancer with tamoxifen were higher for older compared … The NSABP P-1 placebo-controlled trial of tamoxifen reported point estimates consistent with higher risks … Cuzick et al, 42 2002 Cuzick et al, 80 2007 Cuzick et al, 74 2015 3573 3566 2-fold relative … Tamoxifen and anastrozole had more effects for women with previous breast lesions (LCIS, ADH, ALH) Risks